Investigating the impact of Ip management in multi center clinical trails on clinical Data integrity and the challenges and opportunities
Keywords Investigational Product (IP), Clinical Trials, Data Integrity, Multicenter Trials, IP Management, Clinical Research, Regulatory Compliance, Trial Efficiency, Supply Chain, Site Management
Effective management of Investigational Products (IP) in multicenter clinical trials is important for maintaining the integrity and quality of clinical data. IP management in a multicenter setting involves activities including procurement, storage, dispensing, reconciliation, and destruction by multiple sites with the potential of different conditions and regulatory environments. Inadequate IP monitoring can lead to protocol deviations, unblinding, or data inconsistencies, which ultimately undermine the scientific integrity of a trial. This research examines the effect of IP administration on clinical data integrity in multicenter trials and identifies the challenges and opportunities involved.Key challenges are site-level practice variations, poor staff training, late shipments, cold-chain failures, inconsistent documentation, and regulatory non-compliance. These contribute to data entry errors, patient safety issues, and heightened audit findings. Additionally, the blinding and randomization procedures' complexity at sites heightens the risk of bias if not effectively controlled.
But the research also identifies major opportunities for enhancing data integrity through solid IP management systems. Some of these include the use of central IP tracking platforms, standardized SOPs, automated controls on inventory, and increased site training programs. Moreover, the use of digital technologies like real-time temperature monitoring, blockchain for supply chain traceability, and e-labeling can further enhance operations and reduce human error.
The results emphasize that systematic and standardized IP management not only protects data quality and compliance with regulations but also optimizes overall trial efficiency. By streamlining the operational and logistic intricacies inherent in multicenter environments, sponsors and CROs can more assuredly guarantee the reliability and reproducibility of trial results.
"Investigating the impact of Ip management in multi center clinical trails on clinical Data integrity and the challenges and opportunities", JETNR - JOURNAL OF EMERGING TRENDS AND NOVEL RESEARCH (www.JETNR.org), ISSN:2984-9276, Vol.3, Issue 5, page no.497-529, May-2025, Available :https://rjpn.org/JETNR/papers/JETNRTH00010.pdf
Volume 3
Issue 5,
May-2025
Pages : 497-529
Paper Reg. ID: JETNR_232121
Published Paper Id: JETNRTH00010
Downloads: 000929
Research Area: Health Science All
Country: Rourkela , Odisha , India
ISSN: 2984-9276 | IMPACT FACTOR: 9.87 Calculated By Google Scholar | ESTD YEAR: 2023
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.87 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: RJPN (IJPublication) Janvi Wave
